Nephros, Inc. (NEPH)
After hours:
- GlobeNewswire
Nephros Receives FDA 510(k) Clearance for HDF Assist Module
The First and Only FDA-Cleared Device Available in the United States to Provide Hemodiafiltration Therapy to Dialysis Patients SOUTH ORANGE, NJ, May 17, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it has received FDA 510(k) clearance for its patented, second-generation HDF Assist Module. The HDF Assist Module is the fir
- GlobeNewswire
Nephros Announces Results for Quarter Ended March 31, 2022
First Quarter Net Revenue of $2.2 Million;Active Customer Sites Climb 17% to New Record SOUTH ORANGE, NJ, May 04, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced financial results for the first quarter ended March 31, 2022. Financial Highlights Water Filtration Business Segment Highlights* Net revenue of $2.2 million, a decrease
- GlobeNewswire
Nephros First Quarter 2022 Financial Results Conference Call
SOUTH ORANGE, NJ, April 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it will file its first-quarter financial results on Wednesday, May 4, 2022 after market close and will host a conference call that same day at 4:30 PM ET. Participants may dial into the call as follows:Domestic access: 1 (844) 808-7106International
